PL3302473T3 - Wytwarzanie cytrynianu sufentanylu i zasady sufentanylu - Google Patents
Wytwarzanie cytrynianu sufentanylu i zasady sufentanyluInfo
- Publication number
- PL3302473T3 PL3302473T3 PL16800663T PL16800663T PL3302473T3 PL 3302473 T3 PL3302473 T3 PL 3302473T3 PL 16800663 T PL16800663 T PL 16800663T PL 16800663 T PL16800663 T PL 16800663T PL 3302473 T3 PL3302473 T3 PL 3302473T3
- Authority
- PL
- Poland
- Prior art keywords
- sufentanil
- preparation
- base
- citrate
- sufentanil citrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562166911P | 2015-05-27 | 2015-05-27 | |
EP16800663.3A EP3302473B1 (en) | 2015-05-27 | 2016-05-25 | Preparation of sufentanil citrate and sufentanil base |
PCT/US2016/034091 WO2016191472A1 (en) | 2015-05-27 | 2016-05-25 | Preparation of sufentanil citrate and sufentanil base |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3302473T3 true PL3302473T3 (pl) | 2020-12-14 |
Family
ID=57393664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL16800663T PL3302473T3 (pl) | 2015-05-27 | 2016-05-25 | Wytwarzanie cytrynianu sufentanylu i zasady sufentanylu |
Country Status (10)
Country | Link |
---|---|
US (4) | US10227335B2 (pl) |
EP (1) | EP3302473B1 (pl) |
JP (3) | JP2018515580A (pl) |
AU (1) | AU2016268344B2 (pl) |
BR (1) | BR112017025115B1 (pl) |
CA (1) | CA2986764A1 (pl) |
ES (1) | ES2806631T3 (pl) |
MX (1) | MX2017015100A (pl) |
PL (1) | PL3302473T3 (pl) |
WO (1) | WO2016191472A1 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3302473B1 (en) * | 2015-05-27 | 2020-07-08 | SpecGx LLC | Preparation of sufentanil citrate and sufentanil base |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3998834A (en) | 1975-03-14 | 1976-12-21 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-n-phenylamides and -carbamates |
US4179569A (en) * | 1975-03-14 | 1979-12-18 | Janssen Pharmaceutica N.V. | N-(4-piperidinyl)-N-phenylamides |
US5039804A (en) * | 1989-12-13 | 1991-08-13 | Glaxo Inc. | Preparation of substituted alkali metal piperidine-4-carboxylates |
US5489689A (en) * | 1993-09-30 | 1996-02-06 | Mallinckrodt Chemical, Inc. | Preparation of piperidine derivatives |
US6342250B1 (en) * | 1997-09-25 | 2002-01-29 | Gel-Del Technologies, Inc. | Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices |
US7074935B2 (en) | 1999-12-06 | 2006-07-11 | Mallinckrodt Inc. | Methods for the syntheses of alfentanil, sufentanil and remifentanil |
US20040187770A1 (en) * | 2001-10-17 | 2004-09-30 | Calabrese Richard V. | Rotor-stator apparatus and process for the formation of particles |
WO2008005423A1 (en) | 2006-07-03 | 2008-01-10 | Cambrex Charles City, Inc. | Improved method of making sufentanil |
CA2677281C (en) | 2007-02-09 | 2019-10-29 | Durect Corporation | Transoral dosage forms comprising sufentanil and naloxone |
WO2010027770A1 (en) * | 2008-09-04 | 2010-03-11 | Mallinckrodt Inc. | Crystalline forms of sufentanil citrate |
US8299258B2 (en) | 2008-11-04 | 2012-10-30 | Cambrex Charles City | Method of making piperidine derivatives |
EP2616464B1 (en) * | 2010-09-17 | 2018-01-03 | Mallinckrodt LLC | Improved process for the preparation of a precursor of sufentanil base |
EP2455377B1 (de) | 2010-11-11 | 2014-07-09 | hameln rds gmbh | Synthese von Fentanyl Analoga |
CN102060753B (zh) * | 2010-12-29 | 2013-01-09 | 宜昌人福药业有限责任公司 | 一种4-苯胺基哌啶类镇痛药的精制方法 |
JP6146613B2 (ja) | 2013-09-04 | 2017-06-14 | 東芝ライテック株式会社 | 自動車用照明装置、および自動車用灯具 |
EP3302473B1 (en) * | 2015-05-27 | 2020-07-08 | SpecGx LLC | Preparation of sufentanil citrate and sufentanil base |
-
2016
- 2016-05-25 EP EP16800663.3A patent/EP3302473B1/en active Active
- 2016-05-25 MX MX2017015100A patent/MX2017015100A/es unknown
- 2016-05-25 AU AU2016268344A patent/AU2016268344B2/en active Active
- 2016-05-25 BR BR112017025115-9A patent/BR112017025115B1/pt active IP Right Grant
- 2016-05-25 PL PL16800663T patent/PL3302473T3/pl unknown
- 2016-05-25 US US15/164,483 patent/US10227335B2/en active Active
- 2016-05-25 WO PCT/US2016/034091 patent/WO2016191472A1/en active Application Filing
- 2016-05-25 JP JP2017561257A patent/JP2018515580A/ja not_active Withdrawn
- 2016-05-25 CA CA2986764A patent/CA2986764A1/en active Pending
- 2016-05-25 ES ES16800663T patent/ES2806631T3/es active Active
-
2019
- 2019-01-22 US US16/254,074 patent/US10899749B2/en active Active
-
2020
- 2020-11-06 US US17/091,109 patent/US20210061793A1/en not_active Abandoned
-
2021
- 2021-01-21 JP JP2021007882A patent/JP2021059609A/ja not_active Withdrawn
-
2022
- 2022-11-08 US US17/983,051 patent/US20230074804A1/en active Pending
- 2022-12-28 JP JP2022211976A patent/JP2023036903A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US10227335B2 (en) | 2019-03-12 |
AU2016268344B2 (en) | 2020-03-26 |
MX2017015100A (es) | 2018-08-09 |
JP2023036903A (ja) | 2023-03-14 |
AU2016268344A1 (en) | 2017-11-30 |
US20230074804A1 (en) | 2023-03-09 |
EP3302473B1 (en) | 2020-07-08 |
US20160347743A1 (en) | 2016-12-01 |
JP2021059609A (ja) | 2021-04-15 |
BR112017025115B1 (pt) | 2023-03-14 |
JP2018515580A (ja) | 2018-06-14 |
BR112017025115A2 (pt) | 2018-07-31 |
US10899749B2 (en) | 2021-01-26 |
US20190152961A1 (en) | 2019-05-23 |
EP3302473A1 (en) | 2018-04-11 |
ES2806631T3 (es) | 2021-02-18 |
EP3302473A4 (en) | 2019-04-17 |
WO2016191472A1 (en) | 2016-12-01 |
CA2986764A1 (en) | 2016-12-01 |
US20210061793A1 (en) | 2021-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL286316A (en) | New micro-dystrophins and related method of use | |
IL250744A0 (en) | A method for preparing flavociclib and its pharmaceutical preparations | |
ZA201805805B (en) | Formulations and methods | |
GB201817116D0 (en) | Pharmaceutical preparation of palbociclic and preparation method thereof | |
IL277814B (en) | Eutectic preparations containing cyclobenzaprine hydrochloride and methods for their preparation | |
HK1248531A1 (zh) | 免疫調節組合物及其使用方法 | |
GB201519128D0 (en) | Solid forms and methods of preparing the same | |
ZA202104969B (en) | Compositions comprising 15-hepe and methods of using the same | |
EP3373910C0 (en) | FORMULATION OF ECHINOMYCIN, METHOD OF MANUFACTURING AND METHOD OF USE THEREOF | |
FI3380525T3 (fi) | Lääkeformulaatioita ja niiden käyttömenetelmiä | |
PT3121318T (pt) | Peça de vestuário e processo de preparação | |
PT3398598T (pt) | Derivado de sulfonamida e método de preparação e utilização do mesmo | |
IL266132A (en) | Pharmacological formulations and methods for their preparation | |
HK1250345A1 (zh) | 包含15-氧代-epa或15-氧代-dgla的組合物及其製備和使用方法 | |
HK1247136A1 (zh) | 包含15-hepe的組合物和其使用方法 | |
IL257027A (en) | Loudspeaker and method of its manufacture | |
IL254794B (en) | Pharmaceutical formulations of a pyridinium compound and a permeability enhancer or base | |
HK1214767A1 (zh) | 片劑形式的藥物組合物及其製造方法 | |
PT3503885T (pt) | Composição farmacêutica e métodos de utilização | |
GB201603591D0 (en) | Improved promotors and compositions | |
PL3302473T3 (pl) | Wytwarzanie cytrynianu sufentanylu i zasady sufentanylu | |
GB201509023D0 (en) | Compositions and methods of production thereof | |
GB201408171D0 (en) | Formulation and method of manufacture | |
IL263526A (en) | Solid state forms of ixazomib citrate | |
ZA201802201B (en) | Novel formulation and treatment methods |